Intratumoral genomic heterogeneity in advanced head and neck cancer detected by comparative genomic hybridization

Adv Otorhinolaryngol. 2005:62:38-48. doi: 10.1159/000082462.

Abstract

Objectives: Little is known about the extent of intratumoral genetic heterogeneity in head and neck squamous cell carcinoma (HNSCC).

Material: Therefore, we examined 79 stage III and IV primary HNSCCs and matched lymph node metastases for over- and underrepresentation of specific chromosome regions by comparative genomic hybridization.

Results: The overall ratio of gains and losses was higher in metastases (M) than in primary (P) tumors (4/1 vs. 2.5/1). Gains of 3q (78.1% P vs. 87.5% M) and 11q (78.1% P vs. 62.5% M), and deletions of 3p (43.8% P vs. 34.4% M) and 9p (31.3% P vs. 15.6% M) were most frequently detected. The highest rate of intratumoral discordance was observed for primary tumors and corresponding metastases (32.8%) compared to matched pairs of 2 metastases (26.5%), and of 2 anatomically distinct sides of 1 primary tumor (24.3%). Furthermore, the discordance rate was dependent on the primary tumor site (oral cavity 49.2%, oropharynx 31%, hypopharynx 30.3% and larynx 27.3%). In some tumors, the extent of genomic discordance argues against a monoclonal origin.

Conclusion: We demonstrate a high individual variation of intratumoral genomic heterogeneity depending on the localization and selection of matched pairs. These findings are of specific importance in view of establishing prognostic markers.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Allelic Imbalance
  • Carcinoma, Squamous Cell / epidemiology
  • Carcinoma, Squamous Cell / genetics*
  • Carcinoma, Squamous Cell / secondary
  • Chromosomes, Human, Pair 11
  • Chromosomes, Human, Pair 3
  • Chromosomes, Human, Pair 9
  • DNA, Neoplasm / analysis
  • Female
  • Gene Amplification
  • Genetic Markers / genetics*
  • Genome
  • Head and Neck Neoplasms / epidemiology
  • Head and Neck Neoplasms / genetics*
  • Head and Neck Neoplasms / pathology
  • Humans
  • In Situ Hybridization, Fluorescence*
  • Lymph Nodes / pathology*
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Nucleic Acid Hybridization
  • Polymerase Chain Reaction / methods
  • Prognosis
  • Sampling Studies
  • Sensitivity and Specificity

Substances

  • DNA, Neoplasm
  • Genetic Markers